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Background: The assessment of neurodevelopmental effects in children associated with prenatal 
methylmercury exposure, from contaminated fish and seafood in the maternal diet, has recently 
been strengthened by adjustment for the negative confounding resulting from co-exposure to 
beneficial polyunsaturated fatty acids (PUFAs).   
Objectives: To determine the cost effectiveness of a periconceptional screening program of 
blood mercury concentration for women planning to become pregnant in Ontario, Canada. Fish 
intake recommendations would be provided for those found to have blood mercury levels above 
the intervention threshold.   
Methods: Analysis was conducted using a combined decision tree/Markov model to compare the 
proposed screening intervention with standard care from a societal perspective over a lifetime 
horizon. The national blood mercury distributions of women aged 20-49 reported in the 
Canadian Health Measures Survey from 2009-2011 were used to determine the cognitive deficits 
associated with prenatal methylmercury exposure for successful planned pregnancies. Outcomes 
modelled included the loss in quality of life and the remedial education costs. Value of 
information analysis was conducted to assess the underlying uncertainty around the model results 
and to identify which parameters contribute most to this uncertainty.  
Results: The incremental cost per QALY gained for the proposed screening intervention was 
estimated to be $18,051 and the expected value for a willingness to pay of $50,000/QALY to be 
$0.61.   
Conclusions: Our findings suggest that the proposed periconceptional blood mercury screening 
program for women planning a pregnancy would be highly cost-effective from a societal 
perspective. The results of a value of information analysis confirm the robustness of the study’s 
conclusions.
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Prenatal mercury (Hg) has been associated with adverse neurodevelopmental effects at exposures 
detected at levels found in the general public from exposure to methylmercury (MeHg) 
contaminated fish and seafood in the diet (Grandjean et al. 2003; Karagas et al. 2012; Oken et al. 
2008).  Subclinical neurotoxic effects, including neurophysiological and neuropsychological 
effects, associated with population level Hg exposures were identified from three prospective 
cohort studies initiated in the 1980s, in the Faroe Islands (Budtz-Jorgensen et al. 2000, 2004; 
Grandjean et al. 1997, 1998), in New Zealand (Crump et al. 1998), and in the Seychelle Islands 
(Myers et al. 2003).  Recently, the importance of adjusting for negative confounding has been 
reviewed (Choi et al. 2008); negative confounding results from co-exposure to beneficial 
polyunsaturated fatty acids (PUFAs) when Hg contaminated fish and seafood is consumed.  A 
strengthened association of prenatal MeHg with adverse neurodevelopmental effects has been 
reported after adjustment for PUFAs as a covariate in prospective cohort studies in the Faroe 
Islands (Budtz-Jorgensen et al. 2007), in the US (Lederman et al. 2008; Oken et al. 2008), and in 
a second cohort in the Seychelle Islands (Strain et al. 2008).  The New Zealand study comprised 
mothers matched on fish intake, thus implicitly included adjustment for PUFAs.  Adverse 
neurodevelopment effects were detected at very low Hg exposures in two US prospective cohort 
studies (Lederman et al. 2008; Oken et al. 2008).   
The World Health Organisation (WHO 2008) recommends adopting a population health 
perspective to assess the burden of exposures that can be reduced by intervention strategies.  One 
such burden is prenatal Hg exposure; the increase in mild mental retardation in a population can 
be calculated from the shift in IQ distribution that results from the cognitive deficits associated 
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with the distribution of Hg exposure in pregnant women, approximated from that in women of 
child-bearing age.   
Several economic analyses have recently been published assessing xenobiotic metal toxicity, 
both mercury and lead, from a societal perspective.  The burden of MeHg neurodevelopmental 
toxicity has been assessed in terms of IQ loss and the associated lost lifetime earnings in the US 
(Rice et al. 2010; Trasande et al. 2005) and in Europe (Bellanger et al. 2013).  The assessment of 
the economic benefits of preventing Hg exposures above three intervention thresholds in Europe 
(Bellanger et al. 2013) was based on the association of prenatal Hg with cognitive deficits 
adjusted for co-exposure to PUFAs, and a lower Hg exposure threshold for adverse effects.  
Roman et al. (2011) recommended development of a dose-response relationship between Hg 
exposure and cardiovascular risk so that this risk can be included in future population health risk 
assessments of Hg.  An estimate of this risk was included in the economic analysis by Rice et al. 
(2010).  Evaluations of the burden of childhood lead (Pb) exposure predate those of prenatal 
MeHg exposure and have been more complex, including consequences of IQ loss in outcomes of 
reduced quality of life and societal costs, such as remedial education costs, and increased 
criminal justice and healthcare costs (Glotzer et al. 1995; Muennig 2009)  A partial cost-benefit 
analysis was conducted for a blood Pb screening program for children from a societal perspective 
in France (Pichery et al. 2011), which included remedial education costs, lost lifetime earnings 
associated with IQ loss and criminal justice system costs.   
The objective of this economic analysis is to estimate the quality of life to be gained from 
reducing prenatal Hg exposures, to determine the cost effectiveness of a periconceptional 
screening program of blood Hg concentration for women planning to become pregnant in 
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Ontario, Canada, from a societal perspective.  The blood Hg distributions [Canadian Health 
Measures Survey (CHMS) 2009-2011] were used to characterize exposures of women aged 20-
49 and IQ loss was calculated using the association, adjusted for PUFAs, of cord blood Hg with 
cognitive deficits.   
Methods 
Study perspective and time horizon 
A societal perspective and a lifetime analytic horizon are appropriate for this study because the 
neurodevelopment effects of prenatal Hg exposure is thought to be persistent and irreversible 
(Debes et al. 2006; Murata et al 2007).  The outcomes modeled are reduced quality of life, 
occurring over a lifetime, and remedial education costs, from junior kindergarten through grade 
12. Remedial education costs are societal, being provided by the Ontario government.   
Intervention strategies 
Two treatment comparators are evaluated for women planning to become pregnant in Ontario, 
the reference case and the intervention case.  The reference case represents the current situation, 
with no assessment of blood Hg level.  The intervention case consists of the proposed blood Hg 
screening program for women planning to become pregnant, between the ages of 20 to 49; the 
fish consumption advice (EPA/FDA 2004), provided for those with levels above the intervention 
threshold, recommends eating two servings of fish per week, substituting small oily fish that are 
high in healthy PUFAs and low in MeHg (e.g. salmon, sole, trout, shrimp) for high Hg fish 
(shark, swordfish, fresh tuna).  Three intervention thresholds are assessed.  The base case uses an 
intervention threshold for maternal blood of 3.4 µg/L.  Two higher intervention thresholds are 
evaluated in the sensitivity analysis, at 8 µg/L and 4.7 µg/L, representing the Canadian 
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provisional interim blood guidance value (Legrand et al. 2010) and this value divided by the 
mean ratio of cord to maternal blood Hg.   
Analytical framework 
A combined decision tree/Markov model, shown in Figure 1, is used to analyse the cost-utility of 
the two treatment comparators.  The cohort is followed from the periconceptional period until 
death.  Prenatal Hg exposure will be closely related to the maternal blood Hg levels during the 
periconceptional period, when the costs of screening and interventions occur, and is represented 
by the decision tree.  The lifelong impacts of mild mental retardation (MMR), defined as having 
an IQ between 50 and 70, associated with prenatal Hg exposure are calculated from the Markov 
part of the model using an annual cycle.  Two outcomes over the lifetime, alive and dead, are 
modeled for the cohort using the 2009 all-cause age specific Ontario mortality rates as the 
transition probabilities from alive to dead, published in the Death Database [Statistics Canada 
(StatCan) 2009].  The proportion of children who are shifted from IQ slightly above 70 to below 
70 by the cognitive deficits associated with their prenatal Hg exposures is calculated from the 
maternal blood Hg distribution and the standard normal IQ distribution.  The only difference 
between the two treatment comparators in the model is the intervention.  The reference case sub-
tree (labelled A in Figure 1) is repeated in the intervention case after the screening and effect of 
dietary recommendations.  The incremental costs of screening, and diet recommendations when 
required, are offset by a reduction in remedial education costs and a relative improvement in 
quality of life from preventing cases of MMR.  The results are modelled using an Excel 
(Microsoft Corporation) spreadsheet, and parameter data used in the model are listed in Table 1.   
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The discount rate used for the base analysis is 5%, as recommended by the Canadian Agency for 
Drugs and Technologies in Health (CADTH) 2006.  Sensitivity analyses are conducted using a 
discount rate of 0, 3%, and a variable discount rate, decreasing from 5% for the first 10 years to 
3% for 5 years to 1% thereafter.   
Distribution of maternal blood Hg 
Total blood Hg level is the biomarker for prenatal exposure available in Canada [Canadian 
Health Measure Survey (CHMS) 2009-2011].  MeHg has a relatively long half-life, about 70 
days, and so comprises 90% of the total blood Hg for the general public, with most resulting 
from eating Hg contaminated fish and seafood (Grandjean et al. 2003; Oken et al. 2008).    The 
CHMS is a national survey which represents 96% of the population aged 3-79, and the prenatal 
exposure for women aged 20-49 was determined from the national blood Hg distributions for 
women aged 20-39 and aged 40-59, extrapolated to Ontario due to limited data.  Reliable 
estimates were reported for geometric mean of 0.66 µg/L (95% CI: 0.47, 0.92) and 75th 
percentile of 1.6 µg/L (95% CI: 1.1, 2.1) for women aged 20-39, and geometric mean of 0.82 
µg/L (95% CI: 0.65, 1.0) and 90th percentile of 2.9 µg/L (95% CI: 1.9, 3.9) for women aged 40-
59 (Table 1).  The survey has a cluster design and estimates are subject to sampling error, those 
estimates with a coefficient of variation between 0 and 16.6% were considered reliable.   
There is no evidence of a threshold value for prenatal Hg below which there are no adverse 
effects, a linear-dose response model describes small adverse effects even at low doses.  
However, the calculation of the benchmark dose (BMD) and the lower limit of its 95% 
confidence interval (BMDL) has been widely adopted to provide an approximate threshold level 
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that Budtz-Jorgensen et al. (2000) state “can be interpreted as a No-Observed Adverse Effect 
level (NOAEL) from experimental studies (Crump, 1995).”  The BMDL has been found to 
depend highly on the dose-response model selected; lower BMDLs resulting from using a 
logarithmic model for cognitive deficits associated with cord blood Hg than when using a linear 
model (Budtz-Jorgensen et al. 2001).  The use of observational data to determine BMDs and 
BMDLs are based on exposures that are seldom measured without error.  Budtz-Jorgensen et al. 
(2004) showed that if this measurement error is ignored, then the BMDLS produced by the 
benchmark approach are biased towards higher and less protective levels.   
This analysis excludes the smallest effects by using a model threshold for adverse effects of 5.8 
μg Hg/L in cord blood.  This value corresponds to the lower benchmark dose (BMDL) divided 
by the composite uncertainty factor of 10 used to derive the reference dose assuming a linear 
dose-response relationship by the National Research Council (NRC 2000). The average of the 
BMDLs using a logarithmic dose-response model for the measure of neurodevelopment most 
sensitive to Hg was similar at about 5 μg/L in cord blood (Budtz-Jorgensen et al. 2000).  The 
mean ratio of cord to maternal blood Hg concentration used in this analysis was 1.7 (95% CI: 
1.0-3.4), reported in a meta-analysis of 10 studies (Stern and Smith 2003), and used in a burden 
of disease analysis by Trasande et al. (2005).   
Five categories of cord blood Hg concentration are used in this analysis: below the model’s 
threshold for adverse cognitive effects, and four categories above it: low, intermediate, high and 
very high.  The cord blood Hg, Hg(Bcord), categories are defined in units of micrograms Hg per 
litre: Hg(Bcord) ≤ 5.8, 5.8 < Hg(Bcord) ≤ 7.3, 7.3 < Hg(Bcord) ≤ 10.2, 10.2 < Hg(Bcord) ≤ 13.0, 
Hg(Bcord) > 13.0.  A probability distribution is used to describe the ratio of cord to maternal 
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blood Hg explicitly, and so the maternal blood Hg categories are defined as the cord blood Hg 
concentration divided by the ratio of cord to maternal blood Hg.  For example, the five categories 
of maternal blood Hg concentration, Hg(Bmat), calculated using the mean ratio of 1.7 for cord to 
maternal blood Hg, in micrograms Hg per litre, are: Hg(Bmat) ≤ 3.4, 3.4 < Hg(Bmat) ≤ 4.3, 4.3 < 
Hg(Bmat) ≤ 6.0, 6.0 < Hg(Bmat) ≤ 7.7, Hg(Bmat) > 7.7.   
Cognitive deficits associated with cord blood Hg concentration 
The association between cord blood Hg and cognitive deficits determined by Budtz-Jorgensen et 
al. (2007) was used in this analysis because this was the only study that adjusted for negative 
confounding from co-exposure to PUFAs, assuming a 100% precision in assessment of fish 
intake, and used structural methods to account for measurement error in the exposure indicators 
and clinical outcomes.  Structural equation models (SEM) include an error term for each 
measured exposure and outcome, and can be used to model the association between the true 
exposure and the true outcome.   
The Hg effects on five statistically significant neurobehavioural outcome functions, for a 
doubling in true Hg exposure, were presented in percentage of the standard deviation (Budtz-
Jorgensen et al. 2007): motor and verbal at 7 years, and motor, attention and verbal, at 14 years, 
at -12.2, -10.8, -9.37, -9.54, and -6.87% sd, respectively.  These values are weighted according to 
the estimated relevance to cognition quantified as IQ points by Cohen et al. (2005), at 0.2 for 
motor domain, 0.6 for verbal domain, and 0.3 for attention domain.  This results in an effect of 
9.4% of SD in IQ distribution (SE 0.93%), equal to 1.4 IQ points (0.094*15pts=1.4 pts) for a 
doubling of prenatal Hg exposure.  This was the value used in Bellanger et al. (2013), the only 
published economic analysis to include adjustment for negative confounding from PUFAs.   
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Bias can result from the choice of dose-response model used in an analysis; more relative 
importance to outliers results from the use of a linear relationship, and more relative importance 
to moderate values results from the use of a logarithmic relationship.  Since cost-utility values 
are used to determine public health priorities, an estimate that is conservative regarding the 
expected benefit of reducing prenatal Hg exposures was deemed appropriate.  This model 
conservatively used a linear dose-response relationship for the moderate Hg exposures, to give a 
lower bound for the expected benefit of reducing these moderate exposures, and a logarithmic 
dose-response relationship for the highest values.  The average IQ losses corresponding to low, 
medium, high and very high maternal blood Hg are: 1⁄8, ½, 1, and 1¼, respectively, of the 9.4% 
of a standard deviation, or 1.4 IQ pts, associated with doubling prenatal Hg.  The probabilistic 
values of these IQ losses are modelled by a gamma probability distribution with shape and scale 
values (101, 0.000926), from the mean of 9.4% (SE 0.93%) of a standard deviation (15 IQ pts).   
Estimated effect of intervention on maternal blood Hg concentration 
The probability and the effectiveness of the intervention in reducing the blood Hg levels were 
derived from the only study published of a similar intervention, a small clinical trial in South 
Korea (Kim et al. 2006).  Maternal screening was conducted in early pregnancy and the 
intervention was a recommendation to avoid eating fish.  The initial and final maternal blood Hg 
concentrations were read off the graph for the 7 women in the intervention group and the 5 
women in the control group with initial blood Hg above 3.4 µg/L.  The intervention was 
successful at reducing the blood Hg below 3.4 µg/L for 6 of those 7 women, modeled as a beta 
distribution with shape and scale of (6, 1).  Its effectiveness was a mean decrease in blood Hg 
(relative to the initial value) of 0.56 (SE 0.11) for a successful intervention, modeled as a beta 
distribution with shape and scale of (11.6, 9.2).  
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Estimated incremental increase in MMR from prenatal Hg exposure 
This analysis adopted the population health approach recommended by the World Health 
Organisation to quantify the burden of neurodevelopmental toxicity of methylmercury as the 
“rate of mild mental retardation caused by methylmercury-related IQ loss” and the concommitant 
loss in quality of life calculated from the methylmercury exposure distribution of the population 
(WHO 2008).  Although there isn’t a clear individual burden from the small subclinical IQ 
deficits that are most common, these small IQ deficits can be significant in a population because 
they can shift the entire IQ distribution.  The individuals who are most heavily impacted are 
children with IQ scores just at the upper IQ threshold for MMR, for whom a lowered IQ score 
would result in a designation of MMR.  It was recommended that the burden of developmental 
neurotoxicity be quantified  
Each MeHg exposure is associated with a specific IQ loss, determined using the standard normal 
IQ distribution.  The proportion of children shifted into the category of MMR (IQ 50-70) are 
those having an IQ between 70 and 70 plus the IQ loss associated with their prenatal Hg 
exposure.  The proportion of potential mothers at each defined blood Hg range is multiplied by 
the proportion of children who would be shifted into MMR by the specific IQ loss associated 
with that prenatal Hg exposure, and the values ranges are summed over the blood Hg ranges.  
This sum is multiplied by the number of live births at each maternal age range, and summed to 
give the total number of MMR cases that could be prevented.  The age-specific infertility rates 
for women (Bushnik et al. 2012), derived from the 2009-2010 cycle of the Canadian Community 
Health Survey, were used to adjust the 2011 age-specific Ontario live births reported in the Birth 
Database [Statistics Canada (StatCan) 2011].  90% of pregnancies planned by women aged 20-
49 result in live births.   
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Quality of life 
Quality adjusted life years are used to estimate the modifiable burden of cognitive deficits from 
prenatal Hg exposure.  Health related quality of life can be characterized using a questionnaire, 
such the EuroQol-5D (EQ5D) or the Health Utility Index Mark 3 (HUI3), which assess the 
severity of 5 and 8 dimensions respectively, and are preference-based, with a value of 1 for 
perfect health and 0 for death (CADTH 2006).  The age-specific QALY values [Canadian 
Community Health Survey (CCHS) 2009-2010] are used to characterize the health-related 
quality of life of people having no change in cognitive category from prenatal mercury exposure.  
Disutility is defined as the loss in health-related utility associated with a single health state or 
disease, and the disutility for MMR (-0.38, sd 0.021) for EQ5D was derived from a study of 
post-meningitis MMR (Oostenbrink et al. 2002).   
Estimated costs 
According to a societal perspective, costs include those for the health care sector, screening all 
women planning to become pregnant and dietary advice for those with blood Hg levels over the 
threshold, and for the education sector, the remedial education for the children shifted into MMR 
(IQ<70) by cognitive deficits due to prenatal Hg exposure.  The incremental cost of screening is 
limited to the laboratory test (women with a family doctor are assumed to have regular 
appointments), at $23.27 fee for the blood Hg test (MOHLTC 2012).  An intermediate family 
doctor appointment, $33.70 (MOHLTC 2013), is also included in the screening cost for orphan 
patients, the roughly 8% of Ontario residents who have no family doctor.  The intervention cost 
is $33.70, for the intermediate appointment at which the family doctor provides fish 
consumptions recommendations.  The remedial education costs are conservatively limited to the 
Ontario Ministry of Education annual Special Education Per-Pupil Amount (SEPPA) from Junior 
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Kindergarten (JK) to Grade 3, Grades 4 to 8, and Grades 9-12, are $931.29, $715.34 and $472.92 
respectively (OME 2012-2013).   
Analysis 
The model calculates the reductions in maternal blood Hg levels achieved by the intervention, 
for maternal blood Hg values above the intervention threshold, whereas IQ losses are calculated 
according to the model threshold for adverse effects.  The analysis presents the total estimated 
costs and QALYs associated with both treatment comparators per live birth in Ontario, and the 
increment cost per QALY gained (ICUR) for the proposed periconceptional blood Hg screening 
program.  The data elements of the base case analysis are presented in Table 1, and the results of 
the analysis using different intervention thresholds are presented in Table 2.   
Sensitivity analysis 
A univariate sensitivity analysis is conducted for changes from the base case relating to discount 
rate, QALY disutilities for MMR of -0.56 and -0.76 based on HUI3 A and B evaluations 
(Oostenbrink et al. 2002), cognitive deficits associated with prenatal Hg assuming a 68% 
precision in PUFA exposure, and inclusion of cost of a family doctor’s appointment for every 
screening case.  The base case assumes that the measurement of PUFA exposure has no error, i.e. 
100% precision.  Since that is unlikely, the sensitivity of the ICUR is evaluated by considering 
the scenario where the fish intake questionnaire has only a 68% precision for assessing PUFA 
exposure, for which motor function at 7 and 14 years were reported to be statistically significant: 
-13.7 and -10.7, respectively by Budtz-Jorgensen et al. (2007).  The ratio of weighted effects 
from Table 2 in Budtz-Jorgensen et al. (2007) was used to determine an effect of 10.6% of SD in 
IQ distribution for a doubling of prenatal mercury exposure assuming 68% precision in PUFA 
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intake.  The intervention threshold used in the base case is the same as the model threshold for 
adverse effects, while the intervention thesholds evaluated in the sensitivity analysis, at 4.7 µg/L 
and 8 µg/L, are higher than the threshold for adverse effects of 3.4 µg/L (Table 2).   
A probabilistic sensitivity analysis is conducted using a Monte Carlo simulation with 5000 
replications.  Probability distributions for nine model parameters are incorporated into the 
analysis: the mean and the standard deviation of the lognormal distribution for blood Hg, for 
women aged 20-39 and aged 40-59, the ratio of cord to maternal blood Hg, the percentage of a 
standard deviation in cognitive deficits effected by a doubling of prenatal Hg exposure, the 
probability and effectiveness of successful intervention, and the disutility associated with MMR.  
Estimates of incremental costs and QALYs are obtained, with 90% confidence intervals, by 
sampling from the probability distributions over 5000 replications.  A cost-effectiveness 
acceptability curve (CEAC) presents the probability that the intervention would be optimal for a 
range of values of willingness to pay for an additional QALY, for the base discount rate of 5%.  
Estimates of incremental cost utility ratio (ICUR) and incremental net benefit (INB) are 
obtained, with 90% confidence intervals.   
Underlying uncertainty within the economic analysis is assessed from a value of information 
analysis.  The expected value of perfect information (EVPI) measures the reduction in 
opportunity loss associated with obtaining perfect information for all parameter values, across a 
range of values for the willingness to pay for an additional QALY.  The partial EVPIs (EVPPIs) 
provide the opportunity loss associated with each parameter, estimated using the quadrature 
method (Coyle and Oakley 2008).  
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The estimated cost of the proposed screening intervention, the base case that has an intervention 
threshold equal to the threshold for adverse effects, is $33.79 per live birth from a planned 
pregnancy, while the estimated cost of the reference case is $2.33.  Table 2 demonstrates that the 
proposed screening program, using the intervention threshold equal to the threshold for adverse 
effects of 3.4 µg/L for maternal blood, dominates those using higher intervention thresholds, 
because the proposed screening program has lower incremental costs and higher incremental 
QALYs.  Therefore, the proposed screening intervention, which has an estimated incremental 
cost per QALY gained of $18,051, is the most affordable intervention to implement as well as 
the one offering the most benefit per unit cost.   
Univariate sensitivity analysis 
The sensitivity of the deterministic incremental cost utility ratio for the screening intervention is 
presented in Table 3.  The results of the univariate sensitivity analysis demonstrate that the 
findings of the base analysis are robust; the ICUR was lower than the base case in all but one 
scenario, in which the screening requires a family doctor appointment for all women planning 
pregnancies, with an ICUR of $35,900.    
Probabilistic sensitivity analysis 
Also in Table 3, the estimated ICUR from the probabilistic sensitivity analysis using a Monte 
Carlo simulation is $18,209, with a 5th percentile ICUR of $9,339 and a 95th percentile of 
$56,555.  The INB of the screening intervention for a willingness to pay of $50,000 per QALY is 
$3.10 (90% CI: -$20.01, $36.53).   
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The cost effectiveness acceptability curve (CEAC), Figure 2, represents the probability that the 
intervention will be cost-effective over a range of values of willingness to pay per QALY gained.  
The CEAC is used to aid decision making by showing the probability that funding the 
intervention would be cost-effective given the uncertainty associated with the parameters used in 
the model.  The CEAC for the proposed screening intervention shows that it would be cost-
effective 75% of the time at a willingness to pay of $30,000/QALY and 93% of the time at 
$50,000/QALY.   
The graph of the expected value of perfect information (EVPI) by willingness to pay, Figure 3, 
rises sharply from zero and peaks near $20,000/QALY at about $5 and declines rapidly to less 
than $0.61 at $50,000/QALY.   
Table 4 presents the EVPI and the EVPPIs for each of the model parameters.  At $50,000 per 
QALY, the EVPI is $0.61 and parameter with the highest EVPPI is the standard deviation of the 
blood Hg distribution of women aged 20-39 ($0.0463) followed by the probability of a 
successful intervention (<$0.00509).   
Discussion 
Ontario had 140,135 live births in 2011: 130,045 (92.8%) born to mothers aged 20-39, and 5,886 
(4.2%) born to mothers aged 40-49.  Of these, we estimate that 14,562 (10.4%) would have been 
born to women with maternal blood Hg above 3.4 µg/L.  Very similar Hg exposure is reported 
for US women of childbearing age in NHANES (1999-2003), with 10% of women aged 15-45 
having blood Hg above 3.5 µg/L (Rice et al. 2010).   In North America, roughly 50% of 
pregnancies are planned (Finer and Zolna 2011), and the Canadian rates are assumed to be very 
similar.  Adjusting for infertility rates, we estimated that 8084 planned pregnancies would have 
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resulted in the planned live births (in Ontario in 2011) having maternal blood Hg levels above 
3.4 µg/L, which could be reduced by the proposed screening and intervention program.   
Fish consumption offers clear benefits, with serum PUFAs correlating with cognitive 
development in two prospective cohort studies (Lederman et al. 2008; Oken et al. 2008).  
However, these studies also reported adverse cognitive effects associated with prenatal Hg 
exposures previously considered safe.  Fish is the main source of protein in many parts of the 
world, and fish consumption advice must balance the risk of adverse health effects of mercury 
with the benefits of essential micronutrients though controversy remains about just what 
constitutes the best balance between these dietary co-exposures(Budtz-Jorgensen et al. 2007, 
Ginsberg and Toal 2009, Karagas et al. 2012).  A screening program for periconceptional blood 
Hg level would support the promotion of healthy fish consumption by reducing anxiety and 
potential elimination of fish from the maternal diet.   
The probabilistic sensitivity analysis estimates the incremental cost-utility ratio for the proposed 
screening intervention at $18,209/QALY (90% C.I.: $9,339/QALY, $56,555/QALY).  Reducing 
cognitive deficits associated with prenatal Hg exposure, by reducing blood Hg level in women 
aged 20-49 planning pregnancies, would be expected to be very cost-effective in Ontario for the 
base case screening program proposed.  Individual benefit would vary widely for this screening 
program, expected to prevent MMR in a few, to prevent a subclinical IQ loss in many, and to 
provide some peace of mind for most.  Although the average incremental QALY gain versus 
reference case would be very low, at 0.0017 (Table 2), the benefit would be substantial for 
individuals in whom MMR, associated with a QALY disutility of -0.38, could be prevented by 
screening for prenatal Hg exposure.  A global treaty to protect human health and the environment 
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from the adverse effects of mercury was adopted on 19th January 2013, the UNEP Minamata 
Convention on Mercury (UNEP), and this analysis demonstrates how cost-effective this 
screening intervention could be for reducing prenatal Hg exposures even when using 
conservative estimates of the potential health benefits.   
A conservative approach is adopted for this analysis, which is limited to adverse 
neurodevelopmental effects of Hg associated with prenatal exposure since a dose-response 
model has not yet been developed to quantify the cardiovascular risk factors associated with Hg 
exposure (Murata et al. 2007).  The results of the univariate sensitivity analysis show that, if our 
assumptions are valid, the proposed screening intervention would be more cost-effective for all 
alternative scenarios considered except when of the cost of a family doctor’s appointment for 
every screening case instead of just for the orphan patients is included.  Since the prevention of 
loss in quality of life would accrue over a lifetime and the prevented remedial education costs 
would accrue until age 17, while the costs of the intervention would occur during the first year, 
the intervention would be more cost-effective at lower discount rates.  The lowest MMR 
disutility value published, of -0.38 (SE 0.021) for EQ-5D, is used in this analysis (Oostenbrink et 
al. 2002).  We estimate that the intervention would be more cost-effective for the assessments of 
larger disutility, with ICURs of $12,249/QALY and $9,026/QALY calculated for the HUI-3A 
disutility, -0.56 (SE 0.026), and the HUI-3B disutility, -0.76 (SE 0.034), respectively.  This 
analysis assumed a 100% precision in fish intake from the questionnaire, whereas a 13% greater 
adverse effect of prenatal Hg exposure is derived assuming 68% precision (based on the average 
of effects on motor function at age 7 and age 14) resulting in an ICUR of $15,660/QALY.  The 
only scenario where the ICUR is higher than the base case was derived from assuming that each 
screening would require a family doctor’s appointment (ICUR of $35,900).   
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The most important limitation of this analysis is the determination of the effectiveness and the 
probability of a successful intervention from a single, very small clinical trial in South Korea 
(Kim et al. 2006).  The proposed intervention would recommend substituting low Hg/high PUFA 
fish for high Hg fish, rather than eliminating fish altogether, as was recommended in the South 
Korean trial.  Korean cuisine is traditionally high in fish, and although the South Korean trial 
intervention required a greater change in individual behaviour, it was still very effective.  Only 
seven women had an initial blood Hg above 3.4 µg/L in the Korean trial, a very small sample, 
and some inaccuracies in blood Hg levels could have resulted from reading the values off the 
graph.  Another data limitation is the small sample size from which the maternal blood Hg 
distribution was derived.  The CHMS used a cluster design and sampled 500 people in each sex-
age category.  This uncertainty is significant because this analysis focussed on the elevated levels 
at the tail of the blood Hg distribution.   
The opportunity cost of making a decision under uncertainty is determined from the uncertainty 
surrounding the cost of the intervention and the value of the outcomes.  The value of information 
analysis suggests that the conclusions concerning the cost effectiveness of the proposed blood 
Hg screening program for women planning to become pregnant in Ontario are robust.  The 
estimated expected value of perfect information shows that the opportunity cost could be reduced 
by reducing the uncertainty of some parameters, and at a threshold value for a QALY of 
$50,000, the model parameters which contribute most to the uncertainty in the ICUR are the 
standard deviation of the blood Hg distribution of women aged 20-39 and the effectiveness of the 
intervention.  It would be feasible to collect further data on the effectiveness of the intervention 
to reduce the uncertainty in the ICUR, by conducting a clinical trial of the proposed intervention 
in Ontario.  This would be especially informative because the values for effectiveness of the 
Environ Health Perspect DOI: 10.1289/ehp.1409034 




proposed intervention used in the analysis were derived from the intervention in the South 
Korean trial.   
Conclusions 
Our estimates suggest that the proposed periconceptional screening intervention for blood Hg 
concentration would be highly cost-effective from a societal perspective.  The estimated 
incremental cost utility ratio is $18,051 per QALY gained, with a probabilistic estimate of 
$18,209/QALY (90% C.I.: $9,339/QALY, $56,555/QALY).  The estimates for the expected 
value of partial perfect information suggest that there would be value in obtaining further 
information to reduce uncertainty about the probability and effectiveness of implementing the 
proposed intervention in Ontario.    
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Table 1. Data Elements of the Economic Model. 
Data element Base analysis Source 
Blood Hg distribution  Canadian Health Measures 
Survey (CHMS) 2009-2011 
Women, age 20-39   
Geometric mean 0.66 µg/L (95% CI: 
0.47, 0.92) 
 
75th percentile 1.6 µg/L (95% CI: 
1.1, 2.1) 
 
Women, age 40-59   
Geometric mean 0.82 µg/L (95% CI: 
0.65, 1.0) 
 
75th percentile 1.7 µg/L (95% CI: 
1.1 2.2) 
 
90th percentile 2.9 µg/L (95% CI: 
1.9, 3.9) 
 
Ratio cord to maternal blood Hg 1.7 Stern and Smith 2003 
Weighted average of standard deviation of 
mercury effect on neurobehavioural test from 
true prenatal exposure doubling 
9.36% Budtz-Jorgensen et al. 
2007 
Intervention  Kim et al. 2006 
Probability of successful intervention   0.857  
Effectiveness of successful intervention   0.556  
Effectiveness of unsuccessful intervention 0  
Live birth rate by maternal age  Statistics Canada (StatCan) 
2011 
Age 20-24 0.122  
Age 25-29 0.280  
Age 30-34 0.345  
Age 35-39 0.181  
Age 40-44 0.039  
Age 45-49 0.003  
Infertility rate by maternal age  Bushnik et al. 2012 
Age 18-24 0.070  
Age 25-29 0.085  
Age 30-34 0.108  
Age 35-39 0.130  
Age 40-44 0.143  
Screening Costs   
Laboratory blood Hg test $23.27 MOHLTC 2012 
Family doctor, intermediate appointment $33.70 MOHLTC 2013 
Remedial Education SEPPA Costs  OME, 2012-2013 
JK-Grade 4 $931.29  
Grades 5-8 $715.34  
Grades 9-12 $472.92  
QALY disutility for MMR (EQ-5D) -0.38 Oostenbrink et al. 2002 
Discount Rate 5% CADTH 2006 
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Abbreviations: EQ-5D: EuroQuol-5D, European quality of life – 5 dimensions; MMR: mild mental 
retardation (IQ between 50 and 70); QALY: quality adjusted life year; SEPPA: special education per 
pupil amount. 
Note: disutility is defined as the loss in utility. 
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Table 2. Estimated Costs and Quality Adjusted Life Years (QALYs) Associated with Maternal 
Blood Hg Screening and Interventions Versus Reference Case. 
Analysis for 















Costs $2.33 $33.79 $33.82 $34.48 
QALYs 18.8676 18.8694 18.8693 18.8686 
Incremental costs versus 
reference case 
 $31.46 $31.49 $32.14 
Incremental QALY 
versus reference case 
 0.001743 0.001707 0.000945 
Incremental cost per 










Abbreviations: Hg(Bcord): cord blood mercury concentration; QALY: quality adjusted life year. 
Note: the model threshold for adverse effects used in the analysis was 3.4 µg/L for all intervention 
thresholds investigated (3.4, 4.7, and 8 µg/L).   
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Table 3. Sensitivity Analysis. 
Univariate Sensitivity Analysis Scenario Estimated incremental cost 
per QALY 
Base case $18,051 
Discount rate of 3% $11,859 
Discount rate of 0% $4,453 
Variable discount rate $10,119 
HUI3 disutility for MMR of -0.56 $12,249 
HUI3 disutility for MMR of -0.76 $9,026 
Precision of 68% in fish intake assessment for mercury effect 
on neurobehavioural tests 
$15,660 
Initial family doctor apt. needed for each Hg(B) screening $35,900 
Probabilistic Sensitivity Analysis  
Average incremental cost per QALY (ICUR)       $18,209          
5th percentile ICUR $9,339 
95th percentile ICUR $56,555 
Incremental net benefit gained versus reference case, for 
20,000 $/QALY 
 
$3.10       
INB, 5th percentile -$20.01 
INB, 95th percentile $36.53 




INB, 5th percentile -$3.56 
INB, 95th percentile $139.08 
Abbreviations: Hg(B): blood mercury concentration; HUI3: health utilities index mark 3; ICUR: 
incremental cost-utility index (i.e. incremental cost per QALY); INB: incremental net benefit; MMR: 
mild mental retardation (IQ between 50 and 70); QALY: quality adjusted life year. 
Note: the HUI3 disutility for MMR represents the loss in utility associated with having mild mental 
retardation assessed using to the Health Utilities Index Mark 3 questionnaire.  
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Table 4. Value of information analysis for screening intervention versus reference case. 









EVPI  ($) 5.30 2.20 0.61 
EVPPI  ($)    
mean Hg(B) of women aged 20-39 1.41 0.02960 5.77E-06 
standard deviation Hg(B) of women aged 20-39 2.08 0.393 0.0463 
mean Hg(B) of women aged 40-49 0 0 0 
standard deviation Hg(B) of women aged 40-49 0 0 0 
ratio of cord/maternal Hg(B) 2.39 0.0606 0 
% of a standard deviation in cognitive deficits 0.444 1.17E-05 0 
probability of a successful intervention 1.08 0.102 0.00509 
effectiveness of a successful intervention 1.24 0.0590 6.12E-04 
disutility for MMR 0.0404 0 0 
Abbreviations: EVPI: expected value of perfect information; EVPPI: expected value of partial perfect 
information; Hg(B): blood mercury concentration; MMR: mild mental retardation (IQ between 50 and 
70); QALY: quality adjusted life year; WTP: willingness to pay. 
Notes: % of a standard deviation in cognitive deficits is used in the model used to quantify the loss in IQ 
points associated with a doubling of true prenatal mercury exposure. Disutility is defined as the loss in 
utility. 
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Figure 1: Combined Decision Tree/Markov Model 
Figure 2: Cost Effectiveness Acceptability Curve. The cost effectiveness acceptability curve 
(CEAC) was derived by plotting the incremental net benefit (INB) for 5000 Monte Carlo 
simulations for each of a range of willingness to pay per QALY. The analysis was based on the 
model assumptions of the base case analysis (Table 1). 
Figure 3: Expected value of perfect information (EVPI) by willingness to pay. The expected 
value of perfect information (EVPI) is derived by calculating, for each value of willingness to 
pay for a QALY, the mean of the 5000 Monte Carlo simulations of the difference between the 
maximum INB of the treatment comparators and the INB of the treatment comparator with the 
best overall ICUR. The analysis was based on the model assumptions of the base case analysis 
(Table 1). INB -incremental net benefit. 
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Willingness to pay  (cost/QALY)
The cost effectiveness acceptibility curve (CEAC) was derived by plotting the incremental net benefit (INB) for 5000 Monte 
Carlo simulations for each of a range of willingness to pay per QALY.  The analysis was based on the model assumptions of 
the base case analysis (Table 1).  
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Willingness to Pay   ($/QALY) 
The expected value of perfect information (EVPI) is derived by calculating, for each value of 
willingness to pay for a QALY, the mean of the 5000 Monte Carlo simulations of the difference 
between the maximum INB of the treatment comparators and the INB of the treatment comparator 
with the best overall ICUR.  The analysis was based on the model assumptions of the base case 
analysis (Table 1).  
INB - incremental net benefit
